Enveric Biosciences, Inc. SEC filings ENVB
Enveric Biosciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 30, 2001. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Jun 9, 2026 | Jun 9, 2026 |
| 424B5 | Prospectus supplement | Jun 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2026 | Jun 8, 2026 |
| S-8 | Employee stock plan registration | Jun 1, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2026 | May 22, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| D | Filing | May 4, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| EFFECT | Filing | Apr 29, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 28, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| S-3 | Shelf registration | Apr 23, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 20, 2026 | Apr 16, 2026 |
| ARS | Annual report to shareholders | Apr 14, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 14, 2026 | — |
| DEF 14A | Proxy statement | Apr 14, 2026 | Apr 14, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2026 | Apr 3, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2026 | Mar 27, 2026 |
| 424B3 | Prospectus | Feb 18, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| D | Filing | Feb 11, 2026 | — |
| S-1 | Registration statement | Feb 10, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 6, 2026 | Feb 6, 2026 |
| 424B5 | Prospectus supplement | Feb 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 28, 2026 | Jan 27, 2026 |
| 424B5 | Prospectus supplement | Jan 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 424B3 | Prospectus | Dec 31, 2025 | — |
| EFFECT | Filing | Dec 30, 2025 | — |
| CORRESP | Letter to the SEC | Dec 29, 2025 | — |
| D | Filing | Dec 23, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 22, 2025 | — |
| S-8 | Employee stock plan registration | Dec 22, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 12, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2025 | Dec 11, 2025 |
| 424B3 | Prospectus | Dec 10, 2025 | — |
| EFFECT | Filing | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| S-3/A | Filing | Dec 5, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| DEF 14A | Proxy statement | Oct 27, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Oct 23, 2025 | Oct 22, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2025 | Oct 10, 2025 |
| D | Filing | Oct 3, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2025 | — |
| S-3 | Shelf registration | Sep 29, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 18, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 29, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 29, 2025 | Aug 26, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | May 29, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| EFFECT | Filing | Apr 17, 2025 | — |
| CORRESP | Letter to the SEC | Apr 16, 2025 | — |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 14, 2025 | Apr 14, 2025 |
| S-3/A | Filing | Apr 10, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 3, 2025 | Jan 30, 2025 |
| 424B4 | Prospectus | Feb 3, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 30, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jan 27, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jan 21, 2025 | Jan 17, 2025 |
| UPLOAD | Letter from the SEC | Jan 21, 2025 | — |
| S-1 | Registration statement | Jan 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2025 | Jan 3, 2025 |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| DEF 14A | Proxy statement | Dec 18, 2024 | Dec 18, 2024 |
| PRER14A | Filing | Dec 12, 2024 | — |
| PRE 14A | Preliminary proxy statement | Nov 27, 2024 | Nov 27, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 12, 2024 | Nov 7, 2024 |
| 424B4 | Prospectus | Sep 12, 2024 | — |
| EFFECT | Filing | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| S-1 | Registration statement | Sep 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 22, 2024 | Aug 22, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 15, 2024 | Jul 10, 2024 |
| UPLOAD | Letter from the SEC | Jul 12, 2024 | — |
| S-3 | Shelf registration | Jul 8, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2024 | May 28, 2024 |
| 8-K |
Current report
Listing notice
|
May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Listing notice
|
May 17, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 424B5 | Prospectus supplement | May 3, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 3, 2024 | May 3, 2024 |
| ARS | Annual report to shareholders | Apr 16, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 16, 2024 | Apr 16, 2024 |
| 8-K | Current report | Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 10-K | Annual report | Mar 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| 424B5 | Prospectus supplement | Mar 11, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 11, 2024 | Mar 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Listing notice
|
Feb 9, 2024 | Feb 6, 2024 |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| EFFECT | Filing | Jan 22, 2024 | — |
| CORRESP | Letter to the SEC | Jan 19, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| S-3 | Shelf registration | Jan 11, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Dec 29, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 28, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 27, 2023 | Dec 27, 2023 |
| 424B4 | Prospectus | Dec 6, 2023 | — |
| EFFECT | Filing | Dec 5, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2023 | Dec 5, 2023 |
| CORRESP | Letter to the SEC | Dec 4, 2023 | — |
| S-1/A | Amended registration statement | Dec 1, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2023 | Nov 29, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2023 | Nov 21, 2023 |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| S-1 | Registration statement | Nov 8, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 6, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 20, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 3, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 20, 2023 | Sep 20, 2023 |
| ARS | Annual report to shareholders | Sep 18, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Sep 18, 2023 | — |
| DEF 14A | Proxy statement | Sep 18, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2023 | Sep 5, 2023 |
| 424B5 | Prospectus supplement | Sep 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 1, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2023 | Jul 17, 2023 |
| UPLOAD | Letter from the SEC | Jul 5, 2023 | — |
| 10-K/A | Amended annual report | Jun 9, 2023 | Dec 31, 2022 |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
May 24, 2023 | May 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2023 | May 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2023 | May 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 15, 2023 | — |
| D/A | Filing | Apr 19, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2023 | Apr 3, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2023 | Mar 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 28, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2023 | Feb 23, 2023 |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Oct 28, 2022 | Oct 28, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENVB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 890821
- Former names
- AMERI Holdings, Inc. (until Dec 30, 2020); SPATIALIZER AUDIO LABORATORIES INC (until May 27, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.